DEFA14A 1 c103328_defa14a.htm

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934 (Amendment No.       )

Filed by the Registrant   [X]
Filed by a Party other than the Registrant   [_]

Check the appropriate box:

[_] Preliminary Proxy Statement
[_] CONFIDENTIAL, FOR USE OF THE COMMISSION ONLY (as permitted by Rule 14a-6(e)(2))
[_] Definitive Proxy Statement
[X] Definitive Additional Materials
[_] Soliciting Material Pursuant to Section 240.14a-12


Pfizer Inc.

(Name of Registrant as Specified In Its Charter)
 
(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)

Payment of Filing Fee (Check all boxes that apply):

[X] No fee required.
 
[_] Fee paid previously with preliminary materials
   
[_]  Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11
     
 

 

 

 

 

Margaret M. Madden

235 East 42nd Street, New York, NY 10017

 

YOUR VOTE IS IMPORTANT - PLEASE VOTE YOUR SHARES TODAY

 

Dear Fellow Pfizer Shareholder:

 

On April 28, 2022, Pfizer will hold its Annual Meeting of Shareholders. We value your input as a holder of Pfizer common stock and encourage you to review our proxy materials and cast your vote today. You can view our proxy materials at https://investors.pfizer.com/proxy.

 

For the reasons set forth in the 2022 Proxy Statement, the Board of Directors recommends that you vote:

 

● “FOR” each director nominee
● “FOR” the ratification of the selection of KPMG LLP as the independent registered public accounting firm for 2022
● “FOR” the 2022 advisory approval of executive compensation
● “AGAINST” the five shareholder proposals.

 

For your convenience, a duplicate proxy/voting instruction card and return envelope are enclosed, along with telephone and Internet voting instructions. In the event that multiple proxies/voting instruction cards are received from you, the one with the latest date will be counted.

 

The 2022 Annual Meeting will be held in a virtual format only. Please view our proxy statement for details on how you can participate.

 

Your vote is important and valued. I encourage you to vote in advance of the Annual Meeting by one of the methods described in the proxy materials and duplicate proxy/voting instruction card. Please act today to be sure your shares are voted.

 

Sincerely,

 

 

 

Margaret M. Madden

Senior Vice President and Corporate Secretary, Chief Governance Counsel

 

Pfizer Inc. – Legal Division

 

Breakthroughs that change patients’ lives pfizer.com